News for Cigna Corporation (CI)

Market Analysis by covering: Boeing Co, Intel Corporation, Alphabet Inc Class A, Cigna Corp. Read 's Market Analysis on Investing.com

The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant shift from Biden-era corporate scrutiny under the new Trump administration.

For 2025, UnitedHealthcare is a substantial opportunity because it has a range of businesses, solid finances, and is investing in upgrading its health services using technology. At the same time…

Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.

Market Analysis by covering: Eli Lilly and Company, Amazon.com Inc, Cigna Corp, CVS Health Corp. Read 's Market Analysis on Investing.com

Market Analysis by covering: S&P 500, Cigna Corp, CVS Health Corp, Unitedhealth Group. Read 's Market Analysis on Investing.com

The Cigna Group (CI) stock experiences a 5% drop following policy changes targeting pharmacy benefit managers. Analysts predict a promising upside for C

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other cheap ...

Oscar Health, Inc. (”œOscar” or the ”œCompany”) (NYSE: OSCR), a leading healthcare technology company, announced today its financial results for the firs

Also in the Forbes CFO newsletter: A mixed bag of economic indicators, the case for shared ownership of data security and a compliance toolkit for small businesses.

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to pricing and access to its drug Zepbound emerged. The company's GLP-1 drugs continue to drive strong revenue growth. Mounjaro is approved by the Food and Drug Administration (FDA) to help adults with type 2 diabetes lower their blood glucose levels, while Zepbound is approved for weight loss in obese adults or overweight adults with at least one weight-related condition, such as high cholesterol or high blood pressure.

On May 5, 2025, Guggenheim analyst Jason Cassorla reiterated a "Buy" rating for Cigna Group (CI). The investment firm continues to express confidence in the com

The Cigna Group (NYSE:CI) Q1 2025 Earnings Conference Call May 2, 2025 8:30 AM ETCompany ParticipantsRalph Giacobbe - Senior Vice President, Investor...

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Cigna Group (NYSE:CI) stock trades higher as the company raises its 2025 earnings outlook after better than expected Q1 2025 financials. Read more here.

The Cigna Group CI will release earnings results for the first quarter, before the opening bell on Friday, May 2. Analysts expect the Bloomfield, Connecticut-b...

Jobs reports, inflation data and earnings will put last week's market rally to the test.

See some of this week's dividend activity along with what is scheduled for next week here.

Investment firm Baird has revised its price target for Cigna Corporation (CI), reducing it from $388 to $362. Despite this adjustment, the firm maintains an Out